A rare case of atropine-resistant bradycardia following sugammadex administration.

Anaphylaxis Bradycardia Cardiac arrest Coronary vasospasm Kounis syndrome Sugammadex

Journal

JA clinical reports
ISSN: 2363-9024
Titre abrégé: JA Clin Rep
Pays: Germany
ID NLM: 101682121

Informations de publication

Date de publication:
02 Mar 2020
Historique:
received: 31 01 2020
accepted: 25 02 2020
entrez: 4 3 2020
pubmed: 4 3 2020
medline: 4 3 2020
Statut: epublish

Résumé

Profound bradycardia caused by sugammadex has been reported, although its mechanism is unclear. Herein, we suggest a possible culprit for this phenomenon. A 50-year-old woman without comorbidity except mild obesity underwent a transabdominal hysterectomy and right salpingo-oophorectomy. After surgery, sugammadex 200 mg was intravenously administered. Approximately 4 min later, her heart rate decreased to 36 bpm accompanied by hypotension (41/20 mmHg) and ST depression in limb lead electrocardiogram (ECG). Atropine 0.5 mg was injected intravenously without improving the hemodynamics. Intravenous adrenaline 0.5 mg was added despite the lack of signs suggesting allergic reactions. Her heart rate and blood pressure quickly recovered and remained stable thereafter, although 12-lead ECG taken 1 h later still showed ST depression. In this case, the significant bradycardia appeared attributable to coronary vasospasm (Kounis syndrome) induced by sugammadex, considering the ECG findings and high incidence of anaphylaxis due to sugammadex.

Sections du résumé

BACKGROUND BACKGROUND
Profound bradycardia caused by sugammadex has been reported, although its mechanism is unclear. Herein, we suggest a possible culprit for this phenomenon.
CASE PRESENTATION METHODS
A 50-year-old woman without comorbidity except mild obesity underwent a transabdominal hysterectomy and right salpingo-oophorectomy. After surgery, sugammadex 200 mg was intravenously administered. Approximately 4 min later, her heart rate decreased to 36 bpm accompanied by hypotension (41/20 mmHg) and ST depression in limb lead electrocardiogram (ECG). Atropine 0.5 mg was injected intravenously without improving the hemodynamics. Intravenous adrenaline 0.5 mg was added despite the lack of signs suggesting allergic reactions. Her heart rate and blood pressure quickly recovered and remained stable thereafter, although 12-lead ECG taken 1 h later still showed ST depression.
CONCLUSIONS CONCLUSIONS
In this case, the significant bradycardia appeared attributable to coronary vasospasm (Kounis syndrome) induced by sugammadex, considering the ECG findings and high incidence of anaphylaxis due to sugammadex.

Identifiants

pubmed: 32124089
doi: 10.1186/s40981-020-00326-7
pii: 10.1186/s40981-020-00326-7
pmc: PMC7052100
doi:

Types de publication

Journal Article

Langues

eng

Pagination

18

Références

J Anesth. 2015 Aug;29(4):641
pubmed: 25672653
J Anesth. 2010 Feb;24(1):143-5
pubmed: 20052499
Korean J Anesthesiol. 2016 Oct;69(5):514-517
pubmed: 27703634
J Pediatr Pharmacol Ther. 2017 Sep-Oct;22(5):378-381
pubmed: 29042841
Anesth Analg. 2018 May;126(5):1505-1508
pubmed: 29064876
J Anesth. 2011 Oct;25(5):790-1
pubmed: 21691923
Int J Cardiol. 2006 Jun 7;110(1):7-14
pubmed: 16249041
J Clin Anesth. 2018 Aug;48:7
pubmed: 29660702
A A Pract. 2019 Jan 1;12(1):22-24
pubmed: 30004912
Int J Cardiol. 2011 Jul 15;150(2):210-1
pubmed: 21636142
Br J Clin Pract. 1991 Summer;45(2):121-8
pubmed: 1793697
Anesth Analg. 2007 Mar;104(3):575-81
pubmed: 17312211
World Allergy Organ J. 2011 Feb;4(2):13-37
pubmed: 23268454
Turk Kardiyol Dern Ars. 2015 Sep;43(6):558-61
pubmed: 26363750
Int J Cardiol. 2014 Sep;176(1):e29-31
pubmed: 25061014
Int J Cardiol. 2009 Oct 2;137(2):e29-32
pubmed: 18804883
Cochrane Database Syst Rev. 2017 Aug 14;8:CD012763
pubmed: 28806470
Anaesthesia. 2009 Mar;64 Suppl 1:38-44
pubmed: 19222430
Br J Anaesth. 2018 Jul;121(1):8-12
pubmed: 29935599
Herz. 2014 Nov;39(7):874-6
pubmed: 23907697
Br J Anaesth. 2018 Jul;121(1):95-96
pubmed: 29935601

Auteurs

Takayuki Yoshida (T)

Department of Anesthesiology, Kansai Medical University Hospital, 2-3-1 Shin-machi, Hirakata-city, Osaka, 573-1191, Japan. ytaka@mac.com.

Chisato Sumi (C)

Department of Anesthesiology, Chibune General Hospital, 3-2-39 Fuku-machi, Nishiyodogawa-ku, Osaka-city, Osaka, 555-0034, Japan.

Takeo Uba (T)

Department of Anesthesiology, Kansai Medical University Hospital, 2-3-1 Shin-machi, Hirakata-city, Osaka, 573-1191, Japan.

Haruka Miyata (H)

Department of Anesthesiology, Baba Memorial Hospital, 4-244 Hamadera-funaocho-higashi, Nishi-ku, Sakai-city, Osaka, 592-8555, Japan.

Takeshi Umegaki (T)

Department of Anesthesiology, Kansai Medical University Hospital, 2-3-1 Shin-machi, Hirakata-city, Osaka, 573-1191, Japan.

Takahiko Kamibayashi (T)

Department of Anesthesiology, Kansai Medical University Hospital, 2-3-1 Shin-machi, Hirakata-city, Osaka, 573-1191, Japan.

Classifications MeSH